State Of Alaska, Department Of Revenue Cara Therapeutics, Inc. Transaction History

State Of Alaska, Department Of Revenue

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	SELL	$4.89 - $12.27 $2,547 - $6,392	-521 Reduced 1.66%	30,909 $151,000
Q4 2022 Jan 11, 2023	BUY	$8.88 - $12.77 $1,642 - $2,362	185 Added 0.59%	31,430 $337,000
Q3 2022 Oct 20, 2022	SELL	$8.24 - $12.56 $6,386 - $9,734	-775 Reduced 2.42%	31,245 $292,000
Q2 2022 Jul 08, 2022	BUY	$7.45 - $13.84 $21,530 - $39,997	2,890 Added 9.92%	32,020 $292,000
Q1 2022 Apr 14, 2022	SELL	$9.94 - $12.65 $7,952 - $10,120	-800 Reduced 2.67%	29,130 $353,000
Q4 2021 Jan 12, 2022	SELL	$11.99 - $18.14 $9,172 - $13,877	-765 Reduced 2.49%	29,930 $364,000
Q3 2021 Oct 07, 2021	BUY	$11.55 - $16.06 $10,568 - $14,694	915 Added 3.07%	30,695 $474,000
Q2 2021 Jul 12, 2021	BUY	$12.38 - $29.19 $368,676 - $869,278	29,780 New	29,780 $424,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $262M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.